Published financial brief
0813B
CRC HEALTH CORP
- As of
- 2012-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 3 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
3 reported periods
| Metric | FY 20102010-12-31 | FY 20112011-12-31 | FY 20122012-12-31 |
|---|---|---|---|
| Financial statements | |||
| RevenueUSD millions | 443 | 446 | 452.3 |
| Cost of goods soldUSD millions | 346.1 | 340.1 | 355.4 |
| Selling, general and administrative expenseUSD millions | —missing | —missing | —missing |
| Depreciation and amortizationUSD millions | 20.9 | 19.7 | 20.3 |
| Net incomeUSD millions | -42 | 12 | 6.9 |
| Operating profit (EBIT)USD millions | 76 | 86.2 | 76.6 |
| Income taxesUSD millions | -3.8 | 11.8 | 9.4 |
| Short-term debtUSD millions | 11.1 | 7.1 | 4.8 |
| Long-term debtUSD millions | 598.9 | 594.6 | 584.5 |
| Cash and equivalentsUSD millions | 7.7 | 10.5 | 19.4 |
| ReceivablesUSD millions | 32.3 | 36.7 | 37.8 |
| InventoryUSD millions | 0 | 0 | 0 |
| PayablesUSD millions | 4.9 | 5 | 6.8 |
| Net property, plant and equipmentUSD millions | 125.6 | 126.8 | 130.4 |
| Capital expenditureUSD millions | 22 | 17.4 | 19.4 |
| Operating cash flowUSD millions | 46.5 | 37.7 | 50.3 |
| Prepaid expensesUSD millions | 8.5 | 8.4 | 4.8 |
| AccrualsUSD millions | 30.9 | 32 | 36.5 |
| EBITDAUSD millions | 96.9 | 106 | 96.9 |
| Working capitalUSD millions | -10 | 6.7 | 12.1 |
| Working capital requirementUSD millions | 27.4 | 31.7 | 31 |
| Total debtUSD millions | 610 | 601.7 | 589.4 |
| Free cash flowUSD millions | 24.5 | 20.2 | 30.9 |
| Unlevered free cash flowUSD millions | 68.7 | 41.6 | 35.2 |
| Returns and ratios | |||
| ROICratio | 4.6% | 2.9% | 2.3% |
| Pre-tax ROICratio | 5% | 5.7% | 5.1% |
| Effective tax rateratio | 8.2% | 49.5% | 56.1% |
| Revenue growthratio | —missing | 0.7% | 1.4% |
| EBIT / Revenueratio | 17.2% | 19.3% | 16.9% |
| Revenue / Invested capitalmultiple | 0.29× | 0.3× | 0.3× |
| Cogs Over Revenuesratio | 78.1% | 76.2% | 78.6% |
| Sga Over Revenuesratio | —missing | —missing | —missing |
| Da Over Revenuesratio | 4.7% | 4.4% | 4.5% |
| Nfa Over Revenuesratio | 28.4% | 28.4% | 28.8% |
| Wcr Over Revenuesratio | 6.2% | 7.1% | 6.9% |
| Debt Over Ebitdamultiple | 6.29× | 5.68× | 6.08× |
| St Debt Over Cashmultiple | 1.45× | 0.67× | 0.25× |
| Interest Over Ebitdamultiple | 0.45× | 0.43× | 0.51× |
| Interest Over Nocf Nicfmultiple | 1.77× | 2.26× | 1.6× |
| Nsf Over Wcrmultiple | 0.13× | -0.11× | -0.47× |
Ask this snapshot
Research assistant
0813B · annualSnapshot 48518976
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000